A new trading day began on Friday, with Quanterix Corp (NASDAQ: QTRX) stock price up 23.81% from the previous day of trading, before settling in for the closing price of $6.51. QTRX’s price has ranged from $4.05 to $10.90 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 9.19% over the last five years. Meanwhile, its annual earnings per share averaged -126.82%. With a float of $38.06 million, this company’s outstanding shares have now reached $46.68 million.
Quanterix Corp (QTRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Quanterix Corp is 18.36%, while institutional ownership is 76.89%. The most recent insider transaction that took place on Sep 12 ’25, was worth 19,878. In this transaction Chief Financial Officer of this company bought 4,150 shares at a rate of $4.79, taking the stock ownership to the 87,200 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director bought 123,990 for $6.14, making the entire transaction worth $760,803. This insider now owns 1,866,933 shares in total.
Quanterix Corp (QTRX) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.3 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -126.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.72% during the next five years compared to 9.19% growth over the previous five years of trading.
Quanterix Corp (NASDAQ: QTRX) Trading Performance Indicators
Here are Quanterix Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.33, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.27 in one year’s time.
